Right to Try for Individualized Treatments Act
Key claim: The Right to Try for Individualized Treatments Act (S4698) was introduced in the 119th Congress and referred to the Senate HELP Committee, seeking to expand Right to Try protections to individualized/experimental treatments.
Abstract
(S4698 · 119th Congress) Latest action (2026-06-08): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
[This finding represents 2 closely related documents issued 2026-06-08 (same source, same action). Related: congress:119-hr-9190:introduced]
Why this matters
Right to Try laws change what treatment pathways are legally available to seriously ill patients outside standard FDA expanded access. Expanding the framework to individualized therapies could affect access to patient-specific investigational treatments (e.g., custom gene or cell therapies), with practical implications for patients seeking bespoke experimental options and for manufacturers navigating liability and FDA oversight.